Endometrium-derived mesenchymal stem cells suppress progression of endometrial cancer via the DKK1-Wnt/β-catenin signaling pathway

BACKGROUND: Mesenchymal stem cell (MSC) therapy is an attractive treatment option for various cancers. Whether MSCs can be used to treat well-differentiated endometrial cancer (EC) remains unclear. The aim of this study is to explore the potential therapeutic effects of MSCs on EC and the underlying...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Yuhui, Hu, Jiali, Lv, Qiaoying, Shi, Chenyi, Qiu, Mengdi, Xie, Liying, Liu, Wei, Yang, Bingyi, Shan, Weiwei, Cheng, Yali, Zhao, Bing, Chen, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249217/
https://www.ncbi.nlm.nih.gov/pubmed/37287079
http://dx.doi.org/10.1186/s13287-023-03387-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10249217/
https://www.ncbi.nlm.nih.gov/pubmed/37287079
http://dx.doi.org/10.1186/s13287-023-03387-4

Ejemplares similares